Ad hoc: Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
8 May 2023
Evotec SE announces that Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc., has entered a multi-year, long-term tech partnership with Sandoz for the immediate development and subsequent manufacturing of multiple biosimilars.